Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |